These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31113731)

  • 1. Deep learning-based quality control of cultured human-induced pluripotent stem cell-derived cardiomyocytes.
    Orita K; Sawada K; Koyama R; Ikegaya Y
    J Pharmacol Sci; 2019 Aug; 140(4):313-316. PubMed ID: 31113731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine-learning-based quality control of contractility of cultured human-induced pluripotent stem-cell-derived cardiomyocytes.
    Orita K; Sawada K; Matsumoto N; Ikegaya Y
    Biochem Biophys Res Commun; 2020 Jun; 526(3):751-755. PubMed ID: 32265031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Changes in Morphology and Function of Human Induced Pluripotent Stem Cell Derived Cardiomyocytes (HiPSC-CMs) Cultured on an Aligned-Nanofiber Cardiac Patch.
    Khan M; Xu Y; Hua S; Johnson J; Belevych A; Janssen PM; Gyorke S; Guan J; Angelos MG
    PLoS One; 2015; 10(5):e0126338. PubMed ID: 25993466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amniotic membrane as novel scaffold for human iPSC-derived cardiomyogenesis.
    Parveen S; Singh SP; Panicker MM; Gupta PK
    In Vitro Cell Dev Biol Anim; 2019 Apr; 55(4):272-284. PubMed ID: 30798515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Transfer in Cardiomyocytes Derived from ES and iPS Cells.
    Stillitano F; Karakikes I; Hajjar RJ
    Methods Mol Biol; 2017; 1521():183-193. PubMed ID: 27910049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Electrophysiological identification of human induced pluripotent stem cell-derived cardiomyocytes].
    Zhang HY; Zhang TT; Machuki JO; Wu LJ; Sun H
    Sheng Li Xue Bao; 2018 Jun; 70(3):281-286. PubMed ID: 29926069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.
    Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L
    Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditioning of hiPSC-derived cardiomyocytes using surface topography obtained with high throughput technology.
    Cortella LRX; Cestari IA; Lahuerta RD; Araña MC; Soldera M; Rank A; Lasagni AF; Cestari IN
    Biomed Mater; 2021 Sep; 16(6):. PubMed ID: 34412045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
    Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
    Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological Characteristics of Human iPSC-Derived Cardiomyocytes for the Assessment of Drug-Induced Proarrhythmic Potential.
    Yamamoto W; Asakura K; Ando H; Taniguchi T; Ojima A; Uda T; Osada T; Hayashi S; Kasai C; Miyamoto N; Tashibu H; Yoshinaga T; Yamazaki D; Sugiyama A; Kanda Y; Sawada K; Sekino Y
    PLoS One; 2016; 11(12):e0167348. PubMed ID: 27923051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A deep learning platform to assess drug proarrhythmia risk.
    Serrano R; Feyen DAM; Bruyneel AAN; Hnatiuk AP; Vu MM; Amatya PL; Perea-Gil I; Prado M; Seeger T; Wu JC; Karakikes I; Mercola M
    Cell Stem Cell; 2023 Jan; 30(1):86-95.e4. PubMed ID: 36563695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-dependent evolution of functional vs. remodeling signaling in induced pluripotent stem cell-derived cardiomyocytes and induced maturation with biomechanical stimulation.
    Jung G; Fajardo G; Ribeiro AJ; Kooiker KB; Coronado M; Zhao M; Hu DQ; Reddy S; Kodo K; Sriram K; Insel PA; Wu JC; Pruitt BL; Bernstein D
    FASEB J; 2016 Apr; 30(4):1464-79. PubMed ID: 26675706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of cytoskeleton features and maturation status of cultured human iPSC-derived cardiomyocytes.
    Zuppinger C; Gibbons G; Dutta-Passecker P; Segiser A; Most H; Suter TM
    Eur J Histochem; 2017 Jun; 61(2):2763. PubMed ID: 28735524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An intermittent rocking platform for integrated expansion and differentiation of human pluripotent stem cells to cardiomyocytes in suspended microcarrier cultures.
    Ting S; Chen A; Reuveny S; Oh S
    Stem Cell Res; 2014 Sep; 13(2):202-13. PubMed ID: 25043964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple protocol to produce mature human-induced pluripotent stem cell-derived cardiomyocytes.
    Knight WE; Cao Y; Dillon P; Song K
    STAR Protoc; 2021 Dec; 2(4):100912. PubMed ID: 34755117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D aggregate culture improves metabolic maturation of human pluripotent stem cell derived cardiomyocytes.
    Correia C; Koshkin A; Duarte P; Hu D; Carido M; Sebastião MJ; Gomes-Alves P; Elliott DA; Domian IJ; Teixeira AP; Alves PM; Serra M
    Biotechnol Bioeng; 2018 Mar; 115(3):630-644. PubMed ID: 29178315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binary Colloidal Crystals Drive Spheroid Formation and Accelerate Maturation of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Cui C; Wang J; Qian D; Huang J; Lin J; Kingshott P; Wang PY; Chen M
    ACS Appl Mater Interfaces; 2019 Jan; 11(4):3679-3689. PubMed ID: 30614683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes by Soluble Factors from Human Mesenchymal Stem Cells.
    Yoshida S; Miyagawa S; Fukushima S; Kawamura T; Kashiyama N; Ohashi F; Toyofuku T; Toda K; Sawa Y
    Mol Ther; 2018 Nov; 26(11):2681-2695. PubMed ID: 30217728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eag Domains Regulate LQT Mutant hERG Channels in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Liu QN; Trudeau MC
    PLoS One; 2015; 10(4):e0123951. PubMed ID: 25923442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-Specific Human Induced Pluripotent Stem Cell Model Assessed with Electrical Pacing Validates S107 as a Potential Therapeutic Agent for Catecholaminergic Polymorphic Ventricular Tachycardia.
    Sasaki K; Makiyama T; Yoshida Y; Wuriyanghai Y; Kamakura T; Nishiuchi S; Hayano M; Harita T; Yamamoto Y; Kohjitani H; Hirose S; Chen J; Kawamura M; Ohno S; Itoh H; Takeuchi A; Matsuoka S; Miura M; Sumitomo N; Horie M; Yamanaka S; Kimura T
    PLoS One; 2016; 11(10):e0164795. PubMed ID: 27764147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.